Bacteria of the genus *Pseudonocardia* associate with fungus-growing ants^[@ref1]^ and produce antibiotics that presumptively play a role in suppressing fungal pathogens in ants' gardens.^[@ref2],[@ref3]^ While *Pseudonocardia* belongs to the Actinomycetales, which are well known for their remarkable ability to produce bioactive secondary metabolites, relatively few natural products have been described from *Pseudonocardia* spp. Antibiotics discovered from *Pseudonocardia* spp. include dentigerumycin,^[@ref3]^ pseudonocardians A and B,^[@ref4]^ phenazostatin D,^[@ref5]^ and NPP.^[@ref6]^ Of these, only dentigerumycin was discovered from a *Pseudonocardia* strain associated with fungus-growing ants, and these symbionts likely have many more undiscovered natural products. As part of our ongoing effort to explore natural products from bacterial symbionts,^[@ref3],[@ref7]−[@ref9]^ we have investigated the natural products from *Pseudonocardia* sp. EC080529-01, isolated from the cuticle of the fungus-growing ant *Apterostigma dentigerum*.^[@ref10]^ This strain produces three new members of the angucycline family of antibiotics,^[@ref11]^ pseudonocardones A (**1**), B (**2**), and C (**3**), along with the known antibiotics 6-deoxy-8-*O*-methylrabelomycin (**4**)^[@ref12]^ and X-14881 E (**5**).^[@ref13]^
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*Pseudonocardia* sp. EC080529-01 was grown on solid ISP-2 medium, and the agar was extracted with EtOAc followed by MeOH. HPLC-MS analysis of the EtOAc extract revealed two peaks with interesting UV spectra (λ~max~ at 381 and 410 nm, respectively). HPLC-MS analysis of the MeOH extract revealed three additional polar peaks with λ~max~ at 348 nm, 388, and 409 nm, respectively. Production cultures of *Pseudonocardia* sp. EC080529-01 were grown on solid ISP-2 medium and extracted with EtOAc followed by MeOH. The EtOAc extract was purified (see [Experimental Section](#sec2){ref-type="other"}) to give 6-deoxy-8-*O*-methylrabelomycin (**4**, 8.3 mg) and X-14881 E (**5**, 3.5 mg). The MeOH extract was purified (see [Experimental Section](#sec2){ref-type="other"}) to give pseudonocardones A (**1**, 2.0 mg), B (**2**, 0.9 mg), and C (**3**, 1.8 mg). The known compounds **4** and **5** were identified by 1D and 2D NMR spectroscopy, and their structures were confirmed by comparison of their spectroscopic data with the literature values.^[@ref12],[@ref13]^

Pseudonocardone A (**1**) gave a peak in the HRESI(+) MS consistent with a molecular formula of C~26~H~24~O~10~. The NMR data (Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} and Table [1](#tbl1){ref-type="other"}) obtained for **1** indicated that it was related to the angucycline family of antibiotics and that it was similar in structure to **5**. The peak in the UV spectrum of **5** at λ~max~ = 410 nm had shifted to λ~max~ = 348 nm. While compound **5** showed two carbon resonances typical of a quinone (δ~C~ 191.3 and 182.0), compound **1** showed only one carbon resonance in this range (δ~C~ 186.0). Instead, compound **1** showed a signal for an oxygenated methine resonance (δ~C~ 66.5; δ~H~ 6.93). This methine resonance showed HMBC correlations to C-6a (δ~C~ 132.5), C-7a (δ~C~ 120.8), C-11 (δ~C~ 123.8), C-11a (δ~C~ 147.7), C-12a (δ~C~ 139.6), and C-12b (121.6), indicating that C-12 is reduced in **1** to give a hydroquinone tautomer rather than a quinone as found in **5**.
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Additional signals were present in the NMR spectra of **1** that could not be attributed to the angucycline core. Subtracting the atoms accounted for by the hydroquinone substructure showed that the remaining fragment had to account for C~6~H~9~O~6~. A series of oxygenated methine resonances in the HSQC spectrum (δ~C~ 73.1--77.1 and δ~H~ 3.63--4.16) and a resonance typical of an anomeric carbon (δ~C~ 103.8 and δ~H~ 5.23) suggested that **1** was glycosylated. An HMBC correlation from the anomeric proton at δ~H~ 5.23 to δ~C~ 156.9 (C-1) showed that **1** was glycosylated at the oxygen atom attached to C-1. A series of COSY and HMBC correlations (Figure [2](#fig2){ref-type="fig"}) revealed that the sugar was a hexose. Finally, HMBC correlations from δ~H~ 3.76 (H-4′) and 4.16 (H-5′) to a carbonyl carbon at δ~C~ 173.0 (C-6′) showed that the sugar had been oxidized to the carboxylic acid at C-6′.
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###### ^1^H and ^13^C NMR Data for Pseudonocardones A (**1**), B (**2**), and C (**3**) Recorded in CD~3~OD at 600 MHz

        pseudonocardone A (**1**)   pseudonocardone B (**2**)   pseudonocardone C (**3**)                           
  ----- --------------------------- --------------------------- --------------------------- --------------- ------- ---------------------
  1     156.9                                                   154.7                                                
  2     114.7                       7.21, s                     115.8                       7.25, s         144.7    
  3     140.5                                                   141.8                                       134.7    
  4     124.0                       7.37, s                     122.9                       7.45, s         120.3   6.95, s
  4a    139.4                                                   135.4                                       131.9    
  5     130.0                       7.78, d (8.8)               134.4                       8.06, d (8.2)   133.0   8.97, d (9.4)
  6     124.5                       8.10, d (8.2)               123.0                       8.16, d (8.8)   122.8   8.17, d (8.8)
  6a    132.5                                                   135.0                                       137.1    
  7     186.0                                                   182.8                                       183.1    
  7a    120.8                                                   120.8                                       119.9    
  8     161.1                                                   160.3                                       160.5    
  9     112.8                       7.13, d (8.2)               118.3                       7.47, d (8.8)   119.3   7.49, d (8.2)
  10    136.0                       7.64, t (7.9)               136.7                       7.78, t (7.9)   136.5   7.75, t (7.9)
  11    123.8                       7.34, d (8.6)               119.3                       7.62, d (7.6)   121.1   7.78, d (7.0)
  11a   147.7                                                   139.9                                       138.4    
  12    66.5                        6.93, s                     189.5                                       190.8    
  12a   139.6                                                   138.8                                       133.2    
  12b   121.6                                                   119.5                                       121.0    
  13    21.8                        2.47, s                     21.6                        2.52, s         17.0    2.50, s
  14    49.4                        3.95, s                     56.4                        4.01, s         56.6    3.99, s
  1′    103.8                       5.23, d (7.6)               101.8                       5.26, d (7.0)   106.6   4.76, d (7.6)
  2′    75.0                        3.93, t (8.8)               74.5                        3.58, m         75.1    3.71, dd (9.1, 7.9)
  3′    77.1                        3.63, t (9.4)               77.1                        3.59, m         77.2    3.50, t (9.1)
  4′    73.1                        3.76, t (9.4)               72.6                        3.60, m         72.9    3.63, t (9.4)
  5′    76.7                        4.16, d (10.0)              76.1                        3.98, d (9.4)   76.8    3.55, d (10.0)
  6′    173.0                                                   172.6                                       173.5    

The relative configuration of the sugar residue in **1** was determined by coupling constants and a NOESY experiment. Large coupling constants (*J* values ranged from 7.6 to 10.0 Hz; see Table [1](#tbl1){ref-type="other"}) indicated that all of the protons must be axial, and therefore the sugar corresponds to β-glucuronic acid. This assignment was supported by NOESY correlations between δ~H~ 5.23 (H-1′) and δ~H~ 3.63 (H-3′), between δ~H~ 5.23 (H-1′) and δ~H~ 4.16 (H-5′), between δ~H~ 3.93 (H-2′) and δ~H~ 3.76 (H-4′), and between δ~H~ 3.63 (H-3′) and δ~H~ 4.16 (H-5′) (Figure [3](#fig3){ref-type="fig"}). The absolute configuration of the sugar moiety was not determined. The absolute configuration of C-12 was also not determined.
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Pseudonocardone B (**2**) gave a peak in the HRESI(+) MS consistent with a molecular formula of C~26~H~22~O~10~. The molecular formula of **2** differed from that of **1** by the loss of two hydrogen atoms. The UV spectrum of **2** also differed significantly from that of **1**, with the low-energy λ~max~ having shifted from 348 nm in **1** to 388 nm in **2**. The NMR data obtained for **2** were very similar to that of **1**, suggesting that the compounds were closely related. The NMR signals corresponding to the C-12 oxygenated methine present in **1** were absent from the NMR spectra of **2**. Instead, the resonance at δ~H~ 7.62 (H-11) showed an HMBC to a carbon at δ~C~ 189.5 (C-12), typical of a quinone carbon, revealing that **2** is the quinone analogue of **1**.

Pseudonocardone C (**3**) gave a peak in the HRESI(+) MS consistent with a molecular formula of C~26~H~22~O~11~. The molecular formula of **3** differed from the molecular formula of **2** by the addition of an oxygen atom. The UV and NMR data obtained for **3** were very similar to that of **2**, suggesting that they are closely related. The aromatic singlet present in **2** at δ~H~ 7.25 (H-2) was absent in the NMR spectrum of **3**, and the other aromatic singlet at δ~H~ 7.45 (H-4) was shifted upfield to δ~H~ 6.95 (H-4) in **3**. The methyl resonance at δ~H~ 2.50 showed an HMBC correlation to a downfield carbon at δ~C~ 144.7 (C-2), suggesting that C-2 was substituted with an oxygen atom. An HMBC correlation from the anomeric proton at δ~H~ 4.76 (H-1′) to C-2 showed that the sugar moiety was attached to C-2 instead of to C-1 as found in **1** and **2**. The lack of protons within three bonds from C-1 made the assignment of this position impossible to determine from the HMBC data. However, in order to satisfy the molecular formula of **3**, C-1 must be oxygenated as it is in **1**, **2**, and **5**.

Compounds **1**--**5** were tested for antibiotic activity against *Escherichia coli* K12, *Bacillus subtilis* 3610, *Candida albicans*, and *Saccharomyces cerevisiae*. Compounds **4** and **5** were active against *B. subtilis* 3610 with MIC values of 25 and 3.13 μg/mL, respectively. None of the compounds showed any activity against *E. coli*, *C. albicans*, or *S. cerevisiae* at concentrations as high as 50 μg/mL. Compounds **1**--**5** were also tested in a liver-stage malaria assay recently developed in one of our laboratories.^[@ref14]^ Compounds **4** and **5** were active against liver-stage *Plasmodium berghei* with IC~50~ values of 18.5 and 3.0 μM, respectively. Finally, compounds **1**--**5** were tested for cytotoxicity against HepG2 cells. Compound **5** was active against HepG2 cells with an IC~50~ value of 36.1 μM. The glycoside analogues (**1**--**3**) were completely inactive against *B. subtilis*, *E. coli*, *C. albicans*, *S. cerevisiae*, and HepG2 cells at concentrations as high as 50 μg/mL and showed only weak activity against liver-stage *P. berghei* with IC~50~ values of 38, 50, and \>100 μM, respectively. The lack of activity for the glycosylated analogues provides insight into the structure--activity relationships of this family of compounds. A comparison of the activity of **2** with that of **5** shows that adding the glucuronic acid moiety at C-1 completely abolishes cytotoxic and antibiotic activity. Glycosylation of antibiotics has been proposed as one possible mechanism of self-resistance,^[@ref15],[@ref16]^ and this might explain the lack of biological activity observed for **1**--**3**.

###### Cytotoxic Activities of **1**--**5** against HepG2 Cells and Antibiotic Activities of **1**--**5** against *P. berghei*, *E. coli*, *B. subtilis*, *C. albicans*, and *S. cerevisiae*[a](#t2fn1){ref-type="table-fn"}

          HepG2   *P. berghei*   *E. coli*   *B. subtilis*   *C. albicans*   *S. cerevisiae*
  ------- ------- -------------- ----------- --------------- --------------- -----------------
  **1**   \>100   38             \>50        \>50            \>50            \>50
  **2**   \>100   50             \>50        \>50            \>50            \>50
  **3**   \>100   \>100          \>50        \>50            \>50            \>50
  **4**   \>100   18.5           \>50        25              \>50            \>50
  **5**   36.1    3.0            \>50        3.13            \>50            \>50

Data represent the average of two experiments each performed in triplicate. The MIC is defined as the lowest concentration that gave less than 5% of the maximum growth.

Experimental Section {#sec2}
====================

General Experimental Procedures {#sec2.1}
-------------------------------

An Agilent 1200 Series HPLC system equipped with a diode array detector and a Phenomenex C~18~ column (5 μm, 250 × 21.2 mm) was used for preparative HPLC. For HPLC-MS analysis, an Agilent HPLC system equipped with a diode array detector and a 6130 Series quadrupole mass spectrometer was used with a Phenomenex C~18~ (5 μm, 100 × 4.6 mm) column. The following gradient was used for HPLC-MS analysis: 0--5 min, isocratic 10% CH~3~CN + 0.1% formic acid; 5--25 min, linear gradient from 10% CH~3~CN + 0.1% formic acid to 100% CH~3~CN + 0.1% formic acid. NMR spectra were recorded in CD~3~OD (for compounds **1**--**4**) or CD~2~Cl~2~ (for compound **5**) at 600 MHz and referenced to the internal solvent peak at δ~H~ 3.30 and δ~C~ 49.0 or δ~H~ 5.32 and δ~C~ 53.8, respectively. High-resolution mass spectrometry (HR-MS) was performed at the University of Illinois Urbana--Champaign Mass Spectrometry Facility.

Isolation of *Pseudonocardia* sp. EC080529-01 {#sec2.2}
---------------------------------------------

An ant colony of *A. dentigerum* was collected from Pipeline Road, Panama, on May 29, 2008, and placed in a sterile Petri dish with moist cotton. After allowing the nest to stabilize for a few days, the *Pseudonocardia* symbiont from this colony was isolated directly from the mesoternal lobe of a worker by scraping bacteria off the cuticle of the ant using a sterile scalpel and plating on chitin media following the methods of Caldera and Currie, and identified as *Pseudonocardia* sp. based on multilocus sequencing.^[@ref10]^

Cultivation of *Pseudonocardia* sp. EC080529-01 {#sec2.3}
-----------------------------------------------

Production cultures of *Pseudonocardia* sp. EC080529-01 were grown on solid ISP-2 medium (per liter: yeast extract, 4 g; malt extract, 10 g; glucose, 4 g) in 12 Petri plates (150 × 20 mm, 1.2 L total) for 7 d at 30 °C. The solid agar was cut into small cubes and soaked in EtOAc (1.2 L) overnight. The EtOAc was filtered and dried *in vacuo* to give the crude EtOAc extract. The solid agar was re-extracted overnight with MeOH (1.2 L), and the MeOH was filtered and dried *in vacuo* to give the crude MeOH extract. The crude EtOAc extract was dissolved in 90% MeOH--H~2~O (20 mL) and passed through a C~18~ column, eluting with additional 90% MeOH--H~2~O, in order to remove nonpolar components. The eluent from this column was diluted with H~2~O to give a final MeOH concentration of 60%. This solution was passed through another C~18~ column and washed with additional 60% MeOH--H~2~O solution, followed by 100% MeOH. The 60% MeOH--H~2~O fraction was purified by preparative HPLC using the following gradient: 0--5 min, isocratic 20% CH~3~CN--H~2~O; 5--60 min, linear gradient from 20% CH~3~CN--H~2~O to 100% CH~3~CN to give pure **4** (8.3 mg). The 100% MeOH fraction from this C~18~ column was purified by preparative HPLC using the following gradient: 0--10 min, isocratic 50% CH~3~CN--H~2~O; 10--60 min, linear gradient from 50% CH~3~CN--H~2~O to 100% CH~3~CN to give pure **5** (3.5 mg). The crude MeOH extract was dissolved in H~2~O and passed through an HP-20 column. The HP-20 column was washed with water to remove polar components, and the compounds of interest were then eluted with 100% MeOH. The 100% MeOH fraction was dried *in vacuo*, redissolved in 60% MeOH--H~2~O, and passed through a C~18~ column to remove nonpolar components. The eluent from this column was diluted with H~2~O to give a final MeOH concentration of 30%. This solution was passed through another C~18~ column and washed with additional 30% MeOH--H~2~O, followed by 100% MeOH. The 100% MeOH fraction from this C~18~ column was purified by reversed-phase HPLC using the following gradient: 0--10 min, isocratic 10% CH~3~CN--H~2~O + 0.1% formic acid; 10--60 min linear gradient from 10% CH~3~CN--H~2~O + 0.1% formic acid to 100% CH~3~CN + 0.1% formic acid to give pure **1** (2.0 mg), **2** (0.9 mg), and **3** (1.8 mg).

### Pseudonocardone A (**1**): {#sec2.3.1}

colorless solid (2.0 mg); \[α\]^20^~D~ −11 (*c* 0.02, MeOH); UV (MeOH) λ~max~ (log ε) 310 nm (3.11), 279 (sh), 271 nm (3.59); ^1^H NMR (600 MHz, CD~3~OD) and ^13^C NMR (150 MHz, CD~3~OD), see Table [1](#tbl1){ref-type="other"}; (+)-HRESI *m*/*z* 497.1438 \[M + H\]^+^ (calcd for C~26~H~25~O~10~, 497.1448).

### Pseudonocardone B (**2**): {#sec2.3.2}

yellow solid (0.9 mg); \[α\]^20^~D~ −2 (*c* 0.02, MeOH); UV (MeOH) λ~max~ (log ε) 377 nm (3.52), 305 nm (3.87); ^1^H NMR (600 MHz, CD~3~OD) and ^13^C NMR (150 MHz, CD~3~OD), see Table [1](#tbl1){ref-type="other"}; (+)-HRESI *m*/*z* 495.1295 \[M + H\]^+^ (calcd for C~26~H~23~O~10~, 495.1291).

### Pseudonocardone C (**3**): {#sec2.3.3}

orange solid (1.8 mg); \[α\]^20^~D~ −3 (*c* 0.09, MeOH); UV (MeOH) λ~max~ (log ε) 403 nm (3.53), 314 nm (3.96); ^1^H NMR (600 MHz, CD~3~OD) and ^13^C NMR (150 MHz, CD~3~OD) see Table [1](#tbl1){ref-type="other"}; (+)-HRESI *m*/*z* 511.1229 (calcd for C~26~H~23~O~11~, 511.1240).

Antibiotic Assays {#sec2.4}
-----------------

The appropriate test organism was grown in a 5 mL culture overnight in either LB medium (for *E. coli* and *B. subtilis*) or YPD medium (for *C. albicans* and *S. cerevisiae*) at 30 °C. In each case, the overnight culture was diluted with additional sterile medium (LB or YPD) to an OD~600~ of 0.01. Compounds **1**--**5** were dissolved in DMSO to give a concentration of 5 mg/mL and 2-fold serially diluted. These solutions (1 μL) were added to the wells of a 96-well plate, followed by the diluted culture of the test organism (99 μL) to give a final compound concentration ranging from 50 to 0.1 μg/mL. The cultures were allowed to grow for 24 h at 30 °C before the OD~600~ was measured using a plate reader. The MIC was defined as the lowest concentration that gave less than 5% of the maximum OD~600~. Each antibiotic assay was performed in duplicate. Dynemicin A was used as a positive control and gave MIC values against *E. coli*, *B. subtilis*, *C. albicans*, and *S. cerevisiae* of 313, 0.16, 156, and 156 ng/mL, respectively.

Cytotoxic Assay {#sec2.5}
---------------

Compounds were tested for activity against HepG2 human hepatoma cells (ATCC) that were maintained in DMEM (Invitrogen), 10% FBS (Sigma), and 1% antibiotic--antimycotic (Invitrogen) in a standard tissue culture incubator (37 °C, 5% CO~2~). For assays, compounds **1**--**5** (in DMSO) were added in triplicate to 15 000 cells in a 384-well plate. The final concentration of DMSO was 1%, and compounds varied from 0 to 50 μg/mL. Cells were incubated with the compounds for 2 days at 37 °C, and then liver cell viability was assessed with CellTiter-Glo (Promega). The relative signal intensity of each sample was evaluated with an EnVision (PerkinElmer) system.

Liver-Stage *P. berghei* Assay {#sec2.6}
------------------------------

Liver-stage *P. berghei* assays were performed using a luciferase-expressing sporozoite strain of *P. berghei* ANKA. Parasites were obtained from dissection of *Plasmodium*-infected *Anopheles stephensi* mosquitoes (New York University Langone Medical Center Insectary). Malaria parasites (4000 sporozoites) were used to infect HepG2 cells (15 000 cells) in a 384-well plate in the presence of compounds **1**--**5** in triplicate. The final concentration of DMSO was 1%, and compounds varied from 0 to 50 μg/mL. Cells were incubated with the compounds for 2 days at 37 °C, and then relative parasite load was determined after addition of Bright-Glo (Promega). Data analysis for HepG2 toxicity and liver-stage malaria activity was carried out using GraphPad Prism, and curves were fit with a standard inhibition dose--response curve to generate an IC~50~ value. All statistical results are the mean IC~50~ value averaged from two independent experiments. Atovaquone was used as a positive control and gave an IC~50~ in blood stage assays of 0.3 nM.

HPLC-MS traces for compounds **1**--**3** and NMR spectra for compounds **1**--**5**. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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